NCT04224389 IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas Status RECRUITING Phase N/A
NCT04201002 Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease. Status COMPLETED Phase N/A
NCT04150900 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04106167 Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy Status TERMINATED Phase N/A
NCT04099446 A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer Status WITHDRAWN Phase N/A
NCT03985670 Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT03982212 A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors Status UNKNOWN Phase PHASE1
NCT03952585 De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03944915 De-Escalation Therapy for Human Papillomavirus Negative Disease Status COMPLETED Phase PHASE2
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Status UNKNOWN Phase N/A
NCT03875859 Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC) Status TERMINATED Phase PHASE2
NCT03854032 Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03841110 FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03837613 Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis. Status UNKNOWN Phase N/A
NCT03802058 Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03791905 PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03758781 IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors Status COMPLETED Phase PHASE1